| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/30/1998 | EP0866855A1 METHOD OF PRODUCING $g(a)2,3-SIALYLTRANSFERASE |
| 09/30/1998 | EP0866853A1 Method of screening for enzyme activity |
| 09/30/1998 | EP0866852A1 Tissue-specific and target rna-specific ribozymes |
| 09/30/1998 | EP0866850A1 Auxinic analogues of indole-3-acetic acid |
| 09/30/1998 | EP0866848A1 Improved neurospora hosts for the production of recombinant proteins, and methods for producing the same |
| 09/30/1998 | EP0866847A1 Extraction system and method |
| 09/30/1998 | EP0866807A1 Porcine cell interaction proteins |
| 09/30/1998 | EP0866799A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 09/30/1998 | EP0866797A1 Glycine and phaseolus alpha-d-galactosidases |
| 09/30/1998 | EP0866796A1 Improvements in or relating to mutagenesis of nucleic acids |
| 09/30/1998 | EP0866721A1 Targeted adenovirus vectors |
| 09/30/1998 | EP0866719A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/30/1998 | EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 09/30/1998 | EP0866716A1 Methods of treating disorders of non-visual sensory epithelia |
| 09/30/1998 | EP0866655A2 Murine model for human carcinoma |
| 09/30/1998 | EP0866654A1 Method for treating hepatitis virus infection |
| 09/30/1998 | EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a |
| 09/30/1998 | EP0643769B1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 09/30/1998 | EP0621873B1 A novel human kunitz-type protease inhibitor and variants thereof |
| 09/30/1998 | CN1194667A Manipulation and detection of protein phosphatase 2C-PP2C alpha-expression in tumor cell for cancer therapy, prevention and detection |
| 09/30/1998 | CN1194666A Device 'Biotron Tszyan-2' for transmitting a natural information supply to a biological object |
| 09/30/1998 | CN1194306A Establish ment of yeast engineering fungus for secreting expression tissue type plasminogen activator |
| 09/30/1998 | CN1194305A 修饰的植酸酶 Modified phytase |
| 09/30/1998 | CN1194270A Decorative ignitor |
| 09/30/1998 | CN1040025C Coding DNA of deaminizing formaenzyme which can increase heat-durability of same |
| 09/30/1998 | CN1040024C Method for inverting plant or plant cell sensitive to deweeding agent |
| 09/29/1998 | US5814716 Cell lines from a transgenic mouse which express biologically active IX factor |
| 09/29/1998 | US5814700 Method for polymer synthesis in a reaction well |
| 09/29/1998 | US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 09/29/1998 | US5814619 Treating with antiproliferative agents, antitumor agents |
| 09/29/1998 | US5814618 Methods for regulating gene expression |
| 09/29/1998 | US5814612 Retinol derivatives and uses thereof |
| 09/29/1998 | US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters |
| 09/29/1998 | US5814604 A pair of polypeptide chains disulfide bonded to form a dimeric species |
| 09/29/1998 | US5814603 Parathyroid hormone peptide with amino acid sequences |
| 09/29/1998 | US5814519 Lymphocyte cell line that expresses cd8 protein on surface |
| 09/29/1998 | US5814510 Attenuated canine parvovirus vaccine |
| 09/29/1998 | US5814509 Isolated dna having nucleotide sequence encoding amino acid sequence of human-originated prostacyclin synthase |
| 09/29/1998 | US5814507 κ/μ-like protein tyrosine phosphatase, PTP λ |
| 09/29/1998 | US5814506 Expression product is substantially free of 3' to 5' exonuclease |
| 09/29/1998 | US5814505 Culture of escherichia for enzyme production |
| 09/29/1998 | US5814502 Storage stable mixture comprising an enzyme, buffers, glycerin, at least one nucleoside triphosphate |
| 09/29/1998 | US5814500 Delivery construct for antisense nucleic acids and methods of use |
| 09/29/1998 | US5814499 Genetic engineering of dna codes of proteins and plasmids |
| 09/29/1998 | US5814493 Genetic engineering and transcription of viruses |
| 09/29/1998 | US5814492 Probe masking method of reducing background in an amplification reaction |
| 09/29/1998 | US5814490 Amplification and detection of chlamydia trachomatis nucleic acids |
| 09/29/1998 | US5814487 Use of agarase enzyme to isolate nucleic acids |
| 09/29/1998 | US5814486 Herpes simplex virus glycoprotein D variants |
| 09/29/1998 | US5814485 Culturing escherichia coli cells transformed with vector comprising sequence encoding interferon polypeptide, culturing in medium with limited concentration of potassium and sodium ions at specified ph |
| 09/29/1998 | US5814484 Yeast cell comprising specified dna molecule producing biologically active polypeptide |
| 09/29/1998 | US5814483 Expression of heterologous polypeptides from a mini Mu vector |
| 09/29/1998 | US5814482 Eukaryotic layered vector initiation systems |
| 09/29/1998 | US5814481 Heat shock-like protein |
| 09/29/1998 | US5814480 Polynucleotide sequence, for detection of the polypeptide in a biological sample |
| 09/29/1998 | US5814479 Genetic engineering for nucleic acid sequence codes of proteins and production |
| 09/29/1998 | US5814478 Isolated nucleotide sequence encoding a polypeptide for treating muscular disorders or nervous system disorders |
| 09/29/1998 | US5814477 Recombinant clostridial toxin protein |
| 09/29/1998 | US5814476 Producing a library of expression vectors; transforming; amplification; screening; isolation |
| 09/29/1998 | US5814475 Antibodies and dna for drugs and diagnosis |
| 09/29/1998 | US5814469 Interleukins, cytokines and tumor necrosis factor for cancer diagnosis |
| 09/29/1998 | US5814465 Biotinated firefly luciferase, a gene for biotinated firefly luciferase, a recombinant DNA, a process for producing biotinated luciferase and a bioluminescent analysis method |
| 09/29/1998 | US5814464 Nucleic acids encoding TIE-2 ligand-2 |
| 09/29/1998 | US5814463 Screening assays using nucleic acids encoding receptors for bombesin-like peptides |
| 09/29/1998 | US5814460 Method for generating and screening useful peptides |
| 09/29/1998 | US5814459 Phosphospecific transcription factor antibodies |
| 09/29/1998 | US5814458 Immunoassay methods for the detection of HIV-1 antibodies employing envelope muteins containing hypervariable domain deletions |
| 09/29/1998 | US5814456 Sperm antigen corresponding to a sperm zone binding protein autoantigenic epitope |
| 09/29/1998 | US5814454 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
| 09/29/1998 | US5814451 Polynucleotides and genetic engineering by bonding |
| 09/29/1998 | US5814450 Amplifying a target sequence of nucleic acid comprising hybridisation, replication and denaturation of nucleic acid in electrochemical cell |
| 09/29/1998 | US5814447 Detecting with a single-stranded oligonuleotide probe bound with a intercalating fluorochrome |
| 09/29/1998 | US5814445 Method of identification and cloning differentially expressed messenger RNAs |
| 09/29/1998 | US5814444 Methods for making and using single-chromosome amplfication libraries |
| 09/29/1998 | US5814441 HTLV-I and HTLV-II peptide antigens and methods |
| 09/29/1998 | US5814320 Eimeria tenella polypeptide and vaccine containing same |
| 09/29/1998 | US5814318 Gene expressing human immunoglobulins by immunizing mouse, specific binding human antigens |
| 09/29/1998 | US5814317 Structural alterations of the EGF receptor gene in human gliomas |
| 09/29/1998 | US5814315 Methods for the suppression of neu mediated phenotype in tumors |
| 09/29/1998 | US5814314 Non-glycosylated, recombinant human IL 2 in reduced form |
| 09/29/1998 | US5814308 Administering macrophage stimulating protein to treat disorders caused by radiation chemotherapy, ulcers or autoimmune diseases, for regeneration of intestinal crypt cells |
| 09/29/1998 | US5814300 Gene-targeted non-human mammals deficient in the SOD-1 gene |
| 09/29/1998 | CA1340063C Production of animal lysozyme c via secretion from pichia pastoris and composition therefor |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/27/1998 | CA2221819A1 Insect expression vectors |
| 09/24/1998 | WO1998041872A1 Method for determining cytokine receptor activation by the use of an antibody |
| 09/24/1998 | WO1998041654A1 In vitro evolution of oligonucleotides |
| 09/24/1998 | WO1998041653A1 An in vitro method for construction of a dna library |
| 09/24/1998 | WO1998041645A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 09/24/1998 | WO1998041644A1 Methods and compositions for genetically modifying primate bone marrow cells |
| 09/24/1998 | WO1998041643A1 Expression control polynucleotides |
| 09/24/1998 | WO1998041642A1 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 09/24/1998 | WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 09/24/1998 | WO1998041640A1 Methods for producing polypeptides in respiratory-deficient cells |
| 09/24/1998 | WO1998041639A1 Serine/threonine protein kinase |
| 09/24/1998 | WO1998041638A1 Phosphatidyl-3,4.5-triphosphate-dependent protein kinase |
| 09/24/1998 | WO1998041636A2 Replication genes and gene products from small cryptic plasmids and methods for constructing high-copy number plasmid vectors |
| 09/24/1998 | WO1998041635A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | WO1998041634A1 Human growth and differentiation protein |
| 09/24/1998 | WO1998041633A1 Human pancreatitis-associated protein, pap-2 |